However, previous paediatric studies, mainly focused on the association of adalimumab TL and ADA with the clinical response, included only children with JIA associated chronic anterior uveitis and cut-off values for obtaining good clinical response were not established. This evidence concerns the gene ADA and juvenile idiopathic arthritis.